Filing Details

Accession Number:
0001209191-23-027852
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-05-08 07:03:54
Reporting Period:
2023-05-05
Accepted Time:
2023-05-08 07:03:54
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
944809 Opko Health Inc. OPK Pharmaceutical Preparations (2834) 752402409
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1867450 J. Gary Nabel 4400 Biscayne Blvd.
Miami FL 33137
Chief Innovation Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-05-05 19,285 $1.78 94,756 No 4 P Direct
Common Stock Acquisiton 2023-05-05 3,185 $1.79 97,941 No 4 P Direct
Common Stock Acquisiton 2023-05-05 27,777 $1.80 125,718 No 4 P Direct
Common Stock Acquisiton 2023-05-05 27,624 $1.81 153,342 No 4 P Direct
Common Stock Acquisiton 2023-05-05 79,334 $1.82 232,676 No 4 P Direct
Common Stock Acquisiton 2023-05-05 19,475 $1.83 252,151 No 4 P Direct
Common Stock Acquisiton 2023-05-05 10,928 $1.83 263,079 No 4 P Direct
Common Stock Acquisiton 2023-05-05 28,538 $1.82 19,886,052 No 4 P Indirect See Footnote
Common Stock Acquisiton 2023-05-05 26,407 $1.85 19,912,459 No 4 P Indirect See Footnote
Common Stock Acquisiton 2023-05-05 54,945 $1.82 19,912,459 No 4 P Indirect See Footnote
Common Stock Acquisiton 2023-05-05 34,338 $1.84 114,338 No 4 P Indirect See Footnote
Common Stock Acquisiton 2023-05-05 54,346 $1.84 168,684 No 4 P Indirect See Footnote
Common Stock Acquisiton 2023-05-05 20,009 $1.85 188,693 No 4 P Indirect See Footnote
Common Stock Acquisiton 2023-05-05 54,054 $1.85 242,747 No 4 P Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Indirect See Footnote
No 4 P Indirect See Footnote
No 4 P Indirect See Footnote
No 4 P Indirect See Footnote
No 4 P Indirect See Footnote
No 4 P Indirect See Footnote
No 4 P Indirect See Footnote
Footnotes
  1. Shares held by the GJN 2021 TRUST for the benefit of the Reporting Person's spouse and descendants, and for which the Reporting Person's spouse serves as co-trustee together with an independent trustee. The Reporting Person's spouse and the independent trustee serve as investment advisors of the trust. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
  2. Shares held by the EGN 2021 TRUST for the benefit of the Reporting Person and his descendants, and for which an independent trustee has been appointed. The Reporting Person and the independent trustee serve as investment advisors of the trust. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
  3. Shares held by the Nabel Family Investments LLC, of which the Reporting Person is the manager with sole investment power and has an approximately 48% interest through the parent trust, the 2009 Nabel Family Children's Trust of which the Reporting Person has sole control, and sole investment power. The Reporting Per disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.